NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products
NHS England
Published on NHS Health Family Atamis procurement portal
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
NHS England awarded this contract to Drugsrus Ltd | Panpharma UK Limited | Accord-UK Ltd | Fresenius Kabi Limited | Kent Pharma Ltd | Wockhardt UK Limited | Luye Pharma Ltd | Bowmed Ibisqus Limited | Aspire Pharma Limited | Morningside Pharmaeuticals | Milpharm Ltd/aurobinbdo Primary | Mylan | Pfizer Ltd | ennogen healthcare ltd | Amarox Limited | Mercury Pharmaceuticals Limited | Novumgen Limited | Teva UK Limited | Neon Healthcare Ltd | Martindale Pharma | Rosemont Pharmaceuticals Limited | Farmak Pharmaceuticals | B. Braun Medical Limited | Dr.Reddy's Laboratories (UK) Limited | hameln pharma ltd | Macleods Pharma UK Limited | Medreich PLC | JCSH Pharma Ltd | Seacross Pharmaceuticals Ltd | Grindeks Kalceks UK Ltd | SVP Pharma Ltd worth £11,656,086 on 16 Apr 2025. The contract runs until 31 May 2027.
Description
Project title: NHS National Framework for the supply of Generics Housekeeping Products & Oral Products, commencing 1 June 2025
Offer reference number: CM/PHG/24/5720
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/24/5720/01 - Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months) NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months) LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months)
CM/PHG/24/5720/02 - Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months) DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months) DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Awarded suppliers (31)
- Drugsrus Ltd
- Panpharma UK Limited
- Accord-UK Ltd
- Fresenius Kabi Limited
- Kent Pharma Ltd
- Wockhardt UK Limited
- Luye Pharma Ltd
- Bowmed Ibisqus Limited
- Aspire Pharma Limited
- Morningside Pharmaeuticals
- Milpharm Ltd/aurobinbdo Primary
- Mylan
- Pfizer Ltd
- ennogen healthcare ltd
- Amarox Limited
- Mercury Pharmaceuticals Limited
- Novumgen Limited
- Teva UK Limited
- Neon Healthcare Ltd
- Martindale Pharma
- Rosemont Pharmaceuticals Limited
- Farmak Pharmaceuticals
- B. Braun Medical Limited
- Dr.Reddy's Laboratories (UK) Limited
- hameln pharma ltd
- Macleods Pharma UK Limited
- Medreich PLC
- JCSH Pharma Ltd
- Seacross Pharmaceuticals Ltd
- Grindeks Kalceks UK Ltd
- SVP Pharma Ltd
Contact
Identifiers
Explore related tenders
Other tenders from NHS England
View all →External ID: cf-ocds-b5fd17-895230db-86c4-4f1f-8915-3b5a187451a2 • Added 3 October 2026